SPECTRUM PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Spectrum Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending March 22, 2023 was 205M shares, a 15.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 205M +28.1M +15.9% Mar 22, 2023 10-K 2023-03-31
Q3 2022 203M +39.2M +23.9% Nov 7, 2022 10-Q 2022-11-14
Q2 2022 188M +24.1M +14.7% Aug 8, 2022 10-Q 2022-08-12
Q1 2022 177M +23.4M +15.2% Mar 10, 2022 10-K 2022-03-18
Q3 2021 164M +18M +12.4% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 164M +18.3M +12.6% Aug 6, 2021 10-Q 2021-08-12
Q1 2021 154M +37.3M +32% Mar 24, 2021 10-K 2021-03-31
Q3 2020 146M +32.9M +29.2% Oct 31, 2020 10-Q 2020-11-04
Q2 2020 146M +32.9M +29.1% Aug 5, 2020 10-Q 2020-08-10
Q1 2020 116M +4.51M +4.02% Apr 30, 2020 10-Q 2020-05-07
Q3 2019 113M +6.06M +5.67% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 113M +6.9M +6.51% Jul 31, 2019 10-Q 2019-08-09
Q1 2019 112M +7.91M +7.6% Apr 30, 2019 10-Q 2019-05-09
Q3 2018 107M +6.25M +6.21% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 106M +21.5M +25.4% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 104M +23.6M +29.4% Apr 30, 2018 10-Q 2018-05-04
Q3 2017 101M +20.1M +25% Oct 31, 2017 10-Q 2017-11-03
Q2 2017 84.5M +4.29M +5.34% Jul 28, 2017 10-Q 2017-08-04
Q1 2017 80.4M +11.2M +16.2% Apr 24, 2017 10-Q 2017-05-04
Q3 2016 80.6M +13.2M +19.6% Oct 31, 2016 10-Q 2016-11-14
Q2 2016 80.2M +12.9M +19.2% Jul 28, 2016 10-Q 2016-08-09
Q1 2016 69.2M +2.23M +3.32% Apr 29, 2016 10-Q 2016-05-06
Q3 2015 67.3M +1.58M +2.4% Oct 31, 2015 10-Q 2015-11-06
Q2 2015 67.3M +1.58M +2.4% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 67M +1.41M +2.15% Apr 30, 2015 10-Q 2015-05-08
Q3 2014 65.8M +1.88M +2.94% Oct 31, 2014 10-Q 2014-11-10
Q2 2014 65.7M +2.42M +3.83% Jul 31, 2014 10-Q 2014-08-08
Q1 2014 65.6M +5.56M +9.26% Apr 28, 2014 10-Q 2014-05-12
Q3 2013 63.9M +4.34M +7.28% Nov 14, 2013 10-Q 2013-11-18
Q2 2013 63.3M +3.06M +5.09% Aug 5, 2013 10-Q/A 2013-11-18
Q1 2013 60M +504K +0.85% Apr 29, 2013 10-Q/A 2013-11-18
Q3 2012 59.5M +2.14M +3.72% Oct 26, 2012 10-Q 2012-11-09
Q2 2012 60.2M +7.05M +13.2% Jul 18, 2012 10-Q 2012-08-08
Q1 2012 59.5M Apr 20, 2012 10-Q 2012-04-27
Q3 2011 57.4M Oct 19, 2011 10-Q 2011-10-28
Q2 2011 53.2M Jul 29, 2011 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.